Pasithea Therapeutics KTTA Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Market Reaction MDLN Q1 2026 Earnings Earnings Per Share Surpasses Estimates Amid Mixed Market Reaction TAK Q1 2026 Earnings SmallerThanExpected Loss Fails to Lift Shares TKC Q4 2025 Earnings EPS of 440 Amid Modest Stock Decline EXR Q1 2026 Earnings Slight EPS Beat Amid Market Headwinds BCRX Q1 2026 Earnings EPS Misses Estimates Stock Rises on Operational Updates